Smart at home screening and monitoring of Anemia and hypertension among antenatal mothers
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Determining the efficacy of Smartphone Application and non user
研究概览
简要总结
Anemia and hypertension are common pregnancy-related conditions that can significantly impact both maternal and fetal health. Anemia, characterized by low red blood cell or hemoglobin levels, can lead to fatigue, weakness, and complications such as preterm birth or low birth weight if untreated. Hypertension, which includes gestational hypertension and preeclampsia, poses risks like organ damage and preterm birth, requiring vigilant monitoring and management. Gestational hypertension typically resolves after childbirth, while preeclampsia demands closer attention.
Effective management of these conditions through routine prenatal care is essential for preventing complications. Monitoring hemoglobin, ferritin levels, and blood pressure, alongside appropriate interventions like iron supplementation, dietary changes, and lifestyle adjustments, helps ensure better maternal and fetal outcomes. In some cases, medications may be prescribed for hypertension management.
This invention introduces a smartphone application-based point of care system designed to monitor and manage anemia and hypertension among antenatal mothers in real time. By providing healthcare providers with a platform for regular health assessments, the app enables early detection and timely interventions, reducing risks for both the mother and baby. This technology can particularly benefit underserved populations by enhancing access to care and improving prenatal health outcomes, offering a modern approach to managing these critical pregnancy conditions.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 35.00 Year(s)(—)
- 性别
- Female
入选标准
- •Hb less than 10 gm/dl Gestational hypertension Chronic hypertension Irrespective of gestational age.
排除标准
- •Ectopic pregnancy molar pregnancy placenta previa Bleeding disorder Liver disorder Renal disorder.
结局指标
主要结局
Determining the efficacy of Smartphone Application and non user
时间窗: 8 weeks
次要结局
- Determining the maternal & fetal morbidity & mortality among the smart phone application user & non user(During delivery- approximate 37 weeks of gestation)
研究者
Soniya
Saveetha institute of medical and technical science
